RxDoctor Payments Data

Kendra Landry, PA

Pediatrics · Shreveport, LANPI 1528602372

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.0% of the total across 258 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 23.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $2,289 and has fallen 88.3% since, to $267 in 2025. Among pediatrics clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,957in general payments, 2019–2025

Across 258 payments — averaging $19.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$1K
  • Novartis$595
  • AbbVie$571
  • Johnson & Johnson$424
  • Mallinckrodt Hospital Products Inc.$380
  • E.r. Squibb & Sons, L.L.C.$290
  • plus $2K from 18 others

What the payments were for

  • Food & beverage$4,85898%
  • Education$992%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,957 in reported general payments places this provider in the 95th percentile of 913 pediatrics providers in Louisiana.

See all pediatrics providers in Louisiana

Medicare billing

Part B allowed, 2024
$3,632
Medicare patients
22
Services billed
63

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MethotrexateMethotrexate Sodium272$9,116
Hydroxychloroquine Sulfate191$6,702
Leflunomide83$5,822
Celecoxib97$2,677
Allopurinol121$1,690
Febuxostat16$1,662
Leucovorin Calcium25$1,079
Sulfasalazine24$558
Colchicine16$330
Folic Acid28$292
Prednisone22$283
Methotrexate SodiumMethotrexate Sodium/Pf16$211
Alendronate Sodium36$125
Methylprednisolone14$78

Paid to pharmacies, not to this prescriber.

Other pediatrics in Shreveport

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →